ProQR Therapeutics NV (PRQR)

2.77 +0.09 (+3.36%) USD  |  NASDAQ  |  Dec 27, 16:00
2.77 0.00 (0.00%) After-Hours: 20:00
More

ProQR Therapeutics Max Drawdown (5Y): 97.50% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for PRQR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
uniQure NV 94.93%
Merus NV 67.42%
argenx SE 38.20%
Pharming Group --
Pharvaris NV --

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -20.39
Beta (5Y) 0.2404
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 106.4%
Historical Sharpe Ratio (5Y) -0.1616
Historical Sortino (5Y) -0.3275
Monthly Value at Risk (VaR) 5% (5Y Lookback) 29.62%